This document discusses urinary lithiasis (kidney stones). It begins by outlining the objectives of understanding the causes, pathogenesis, and classification of kidney stones. It then reviews the epidemiology of kidney stones, including risk factors like gender, age, geography, climate, occupation, BMI, and water intake. Finally, it examines the physicochemistry of stone formation, including the states of urine saturation, nucleation and crystal growth, and the roles of inhibitors and promoters in the crystallization process.
This document summarizes urinary lithiasis (kidney stones). It discusses the epidemiology, including higher rates in men, those aged 40-70, and people in hot climates. Risk factors include obesity, diabetes, family history, low fluid intake, and occupational heat exposure. It also covers the physicochemistry of stone formation including supersaturation, nucleation, crystal growth and retention. Specific stone types like calcium and oxalate stones are examined in depth, outlining related conditions, diagnostic evaluations, and potential treatments.
Urinary stones form through a multi-step process of supersaturation, nucleation, crystallization, aggregation, and matrix formation. Supersaturation depends on urinary pH, ionic strength, complexation, and solute concentration. Crystals nucleate and grow on surfaces like Randall's plaque or crystal matrix. Inhibitors like citrate, magnesium, and glycosaminoglycans prevent crystal formation and growth while promoters like infection, anatomy, and uric acid increase risk. Maintaining proper levels of inhibitors and limiting promoters can help prevent urolithiasis.
Urolithiasis refers to kidney stone formation. The lifetime prevalence of kidney stones is 1-15%, with peak prevalence occurring in adults aged 60-69 years old. Males are more affected than females. Risk factors include age, gender, geography, climate, occupation, obesity, and medical conditions like diabetes. Stone formation occurs through a process where urine becomes supersaturated, crystals nucleate, aggregate, and are retained in the kidneys. The balance between substances that promote or inhibit crystallization and stone growth determine whether stones will form.
Multicystic dysplastic kidney (MCDK) is a congenital abnormality characterized by multiple cysts replacing renal parenchyma. It results from ureteric bud obstruction during fetal development. Unilateral MCDK is usually asymptomatic and detected incidentally, while bilateral MCDK is fatal due to end-stage renal disease. Diagnosis is made using ultrasound and DMSA renal scan showing nonfunctional cystic kidneys. Treatment involves monitoring unilateral cases and supportive care for bilateral cases.
This document discusses urinary lithiasis and the physicochemistry of kidney stone formation. It describes the concepts of concentration product, solubility product, and formation product which define the different states of saturation in urine - undersaturated, metastable, and unstable. Several important urinary inhibitors that prevent crystallization are discussed, including nephrocalcin, Tamm-Horsfall protein, osteopontin, and citrate. Randall's plaques are described as sites where calcium oxalate stones can nucleate and grow. The matrix component of stones is summarized as well.
This document provides an overview of urinary lithiasis (kidney stone disease) including its epidemiology, etiology, pathogenesis, and classification. Some key points:
- Kidney stone disease prevalence has been increasing globally due to westernization and is most common in middle-aged adults.
- Stones form when urine becomes supersaturated, allowing crystals to nucleate and grow. Inhibitors normally prevent this but may be insufficient in stone formers.
- Calcium stones are most common and result from hypercalciuria in many cases. Other stone types include uric acid, struvite, and cystine stones.
- Multiple dietary, medical, and genetic factors influence stone risk by affecting urine
Dental caries is caused by an imbalance between demineralization and remineralization of tooth enamel and dentin. It is a bacterial infection resulting from acids produced during bacterial metabolism of dietary carbohydrates. Key factors in the development of caries include the oral bacteria Streptococcus mutans, frequent consumption of fermentable carbohydrates, and conditions like low saliva flow that reduce the buffering capacity of saliva. The caries process involves a dynamic interplay over time between demineralization of enamel during periods of acid production, and remineralization when pH rises. If demineralization exceeds remineralization, it can lead to cavitation and destruction of tooth structure.
Nephrolithiasis, commonly known as kidney stones, refers to the formation of hard mineral and salt deposits within the kidneys or urinary tract. These stones can vary in size, ranging from tiny grains to larger, more substantial formations. Nephrolithiasis is a relatively common condition and can affect people of all ages, although it is more prevalent in adults.
This document summarizes urinary lithiasis (kidney stones). It discusses the epidemiology, including higher rates in men, those aged 40-70, and people in hot climates. Risk factors include obesity, diabetes, family history, low fluid intake, and occupational heat exposure. It also covers the physicochemistry of stone formation including supersaturation, nucleation, crystal growth and retention. Specific stone types like calcium and oxalate stones are examined in depth, outlining related conditions, diagnostic evaluations, and potential treatments.
Urinary stones form through a multi-step process of supersaturation, nucleation, crystallization, aggregation, and matrix formation. Supersaturation depends on urinary pH, ionic strength, complexation, and solute concentration. Crystals nucleate and grow on surfaces like Randall's plaque or crystal matrix. Inhibitors like citrate, magnesium, and glycosaminoglycans prevent crystal formation and growth while promoters like infection, anatomy, and uric acid increase risk. Maintaining proper levels of inhibitors and limiting promoters can help prevent urolithiasis.
Urolithiasis refers to kidney stone formation. The lifetime prevalence of kidney stones is 1-15%, with peak prevalence occurring in adults aged 60-69 years old. Males are more affected than females. Risk factors include age, gender, geography, climate, occupation, obesity, and medical conditions like diabetes. Stone formation occurs through a process where urine becomes supersaturated, crystals nucleate, aggregate, and are retained in the kidneys. The balance between substances that promote or inhibit crystallization and stone growth determine whether stones will form.
Multicystic dysplastic kidney (MCDK) is a congenital abnormality characterized by multiple cysts replacing renal parenchyma. It results from ureteric bud obstruction during fetal development. Unilateral MCDK is usually asymptomatic and detected incidentally, while bilateral MCDK is fatal due to end-stage renal disease. Diagnosis is made using ultrasound and DMSA renal scan showing nonfunctional cystic kidneys. Treatment involves monitoring unilateral cases and supportive care for bilateral cases.
This document discusses urinary lithiasis and the physicochemistry of kidney stone formation. It describes the concepts of concentration product, solubility product, and formation product which define the different states of saturation in urine - undersaturated, metastable, and unstable. Several important urinary inhibitors that prevent crystallization are discussed, including nephrocalcin, Tamm-Horsfall protein, osteopontin, and citrate. Randall's plaques are described as sites where calcium oxalate stones can nucleate and grow. The matrix component of stones is summarized as well.
This document provides an overview of urinary lithiasis (kidney stone disease) including its epidemiology, etiology, pathogenesis, and classification. Some key points:
- Kidney stone disease prevalence has been increasing globally due to westernization and is most common in middle-aged adults.
- Stones form when urine becomes supersaturated, allowing crystals to nucleate and grow. Inhibitors normally prevent this but may be insufficient in stone formers.
- Calcium stones are most common and result from hypercalciuria in many cases. Other stone types include uric acid, struvite, and cystine stones.
- Multiple dietary, medical, and genetic factors influence stone risk by affecting urine
Dental caries is caused by an imbalance between demineralization and remineralization of tooth enamel and dentin. It is a bacterial infection resulting from acids produced during bacterial metabolism of dietary carbohydrates. Key factors in the development of caries include the oral bacteria Streptococcus mutans, frequent consumption of fermentable carbohydrates, and conditions like low saliva flow that reduce the buffering capacity of saliva. The caries process involves a dynamic interplay over time between demineralization of enamel during periods of acid production, and remineralization when pH rises. If demineralization exceeds remineralization, it can lead to cavitation and destruction of tooth structure.
Nephrolithiasis, commonly known as kidney stones, refers to the formation of hard mineral and salt deposits within the kidneys or urinary tract. These stones can vary in size, ranging from tiny grains to larger, more substantial formations. Nephrolithiasis is a relatively common condition and can affect people of all ages, although it is more prevalent in adults.
how the dental calculus contributes in progression gingival disease and bone destruction, types of calculus,formation theories,calculus attachment to dental calculus,detection methods
This document discusses the evaluation of renal stones in children. It begins with a case scenario of a 15-year-old boy presenting with left flank pain and hematuria. It then provides introductions to kidney stones, urolithiasis, nephrolithiasis, and nephrocalcinosis. The document discusses the epidemiology, incidence, stone formation process, types of kidney stones including calcium, uric acid, struvite and cystine stones. It outlines risk factors, pathophysiology, approach to diagnosis including detailed history, clinical examination, investigations such as imaging tests, urine analysis and blood tests. It provides details on imaging findings, normal urine constituent levels, the method of stone analysis and algorithms
This document summarizes urinary lithiasis (kidney stones). It discusses the epidemiology, physicochemistry, and classification of stones. Key points include that stone prevalence is highest in white males aged 40-60 and in hot, dry climates. Stones form when the concentration product of stone-forming salts in urine exceeds the solubility product, allowing crystallization. Randall's plaques act as nucleation sites for stone formation in the kidney. The document also outlines various metabolic abnormalities that can cause different stone compositions, like hypercalciuria, hyperoxaluria, and hypocitraturia.
The document discusses renal calculi (kidney stones). It outlines factors in the environment that can contribute to kidney stone formation, including physical activity, work environment, nutrition, body mass, gender, ethnicity, and geographic location. It describes the normal functions of the kidneys and how alterations in physiological mechanisms can lead to renal calculus. Common types of stones are discussed along with their contributing factors and treatment options. Pharmacological treatments include thiazide diuretics, allopurinol, and sodium bicarbonate. Nursing considerations for patients taking these medications focus on monitoring for side effects and complications.
Cholelithiasis, or gallstones, can be either cholesterol stones or pigment stones. Cholesterol stones form when bile becomes supersaturated with cholesterol, while pigment stones are caused by elevated bilirubin levels. Risk factors for cholesterol stones include obesity, rapid weight loss, female sex hormones, and certain genetic disorders. Risk factors for pigment stones include chronic hemolytic anemias and infections of the biliary tract. Gallstones may be asymptomatic but can also cause pain, inflammation of the gallbladder or bile ducts, and other complications if they obstruct ducts or erode into other organs.
2nd year_SGD_Physiology of Liver & Gallbladder.pptmunshi5
The document provides an overview of the functions of the liver and gallbladder. It begins with learning objectives focused on describing the key functions and physiological mechanisms. It then covers the anatomical structures and blood supply of the liver and biliary system. The major sections provide details on the liver's secretory, metabolic, detoxification and other functions. Specific contents of bile like bile salts and pigments are discussed. Clinical correlations regarding jaundice, hepatitis, cirrhosis and gallstones are also summarized. Relevant liver function tests are outlined.
This document provides a case history and overview of cholelithiasis (gallstones). It begins with the case history of a 55-year-old male admitted with abdominal pain and vomiting who was diagnosed with acute gangrenous cholecystitis based on imaging. It then discusses the anatomy and physiology of the gallbladder, definitions and classifications of gallstones, risk factors, pathogenesis, clinical manifestations, diagnostic evaluations, and management. Management options discussed include nutritional therapy, pharmacological therapy, non-surgical methods like lithotripsy, and surgical methods like laparoscopic cholecystectomy.
This document provides an overview of alternatives to cholecystectomy for treating cholelithiasis (gallstones). It discusses the history and epidemiology of gallstone disease and outlines various nonsurgical treatment options including dissolution therapy using medications like ursodeoxycholic acid, extracorporeal shockwave lithotripsy to break up stones, and percutaneous techniques to remove stones. While cholecystectomy has long been the standard treatment, this document explores less invasive alternatives that may be suitable for certain patients depending on factors like stone composition and gallbladder function.
The document discusses theories of dental calculus formation. It describes calculus as mineralized dental plaque composed primarily of calcium phosphate. Several theories are presented on how calculus forms, including the booster mechanism, epitactic theory, inhibition theory, transformation theory, and enzymatic theory. The document also discusses the composition, prevalence, and etiological significance of calculus in periodontal disease progression.
This document provides an overview of renal stones (kidney stones). It discusses the classification of stones by location and chemical composition, which includes calcium salts, uric acid, magnesium ammonium phosphate, and cystine stones. The causes, risk factors, and pathogenesis of different stone types are explained. For example, calcium oxalate stones may be caused by hypercalcemia, hypercalciuria, or hyperoxaluria. The document also covers the morphology, clinical features, diagnosis, and treatment of renal stones.
This document provides an overview of renal stones (kidney stones). It discusses the classification of stones by location and chemical composition, which includes calcium salts, uric acid, magnesium ammonium phosphate, and cystine stones. The causes, risk factors, and pathogenesis of different stone types are explained. Calcium oxalate and uric acid stones are the most common. The document also covers the morphology, clinical features, diagnosis, and treatment of renal stones.
The document describes the anatomy and physiology of the urinary tract and kidney, risk factors and types of kidney stones, and methods for diagnosing and treating stones, including increasing fluid intake, altering diet, using medications to change urine composition, and surgically removing stones with procedures like ureteroscopy and lithotripsy. Kidney stones form when substances like calcium, oxalate, and uric acid become supersaturated in the urine and crystallize into solid masses.
Stone disease evaluation in Pathology laboratory: Current prospective.Sanjeev Mehta
This document discusses metabolic evaluation and stone analysis for kidney stones. It explains that stone analysis identifies the stone composition and underlying causes, which helps determine the appropriate treatment plan. A variety of tests are used, including blood and urine tests, 24-hour urine collection to measure supersaturation levels, and analyzing the stone composition. Integrating the results of these analyses can identify metabolic abnormalities and other factors in 90-95% of cases, guiding personalized medical management and prevention of future stone recurrences.
This document discusses urinary stone disease (kidney stones). It reviews the epidemiology, risk factors, pathogenesis and types of kidney stones. It also reviews guidelines for management from the American Urological Association. The main points are:
- Kidney stone prevalence is increasing worldwide, especially for calcium stones. Risk factors include metabolic syndrome, obesity, diabetes and cardiovascular disease.
- The major stone types are calcium oxalate, calcium phosphate, uric acid and struvite. Composition depends on urine composition and risk factors.
- Pathogenesis involves supersaturation of urine leading to crystallization of stone-forming substances. Hypocitraturia and hyperoxaluria are common contributing factors.
-
The document discusses diarrhea and constipation, and treatments for each. It describes antidiarrheal agents that work by adsorption, decreasing motility, modifying intestinal flora, or decreasing motility. Side effects include electrolyte imbalances, constipation, and drug interactions. Laxatives are used to treat constipation and work by bulking stool, lubricating, drawing water into intestines, or increasing motility. Side effects include electrolyte issues, cramps, and dependency with long term use. Nursing implications include assessing for dehydration and educating patients.
Kidney stones form when minerals crystallize and separate from urine inside the kidney. They are typically small in size but can cause pain by blocking the flow of urine. Common symptoms include pain during urination, back pain, and blood in the urine. While diet and dehydration are key risk factors, kidney stones sometimes form without a clear cause. Diagnosis involves x-rays or ultrasounds to detect stones in the kidneys or ureters. Shock wave lithotripsy is a common treatment that uses sonic waves to break up stones so they can pass naturally in urine.
1. Dental plaque plays a key role in the development of dental caries by acting as a barrier that prevents saliva from neutralizing acids and remineralizing enamel. Within plaque, cariogenic bacteria like Streptococcus mutans ferment sugars into acids that dissolve enamel.
2. Frequent sugar consumption promotes the growth of cariogenic bacteria in plaque and shortens the time between acid attacks on teeth before remineralization can occur, increasing the risk of caries. Sucrose is particularly cariogenic.
3. Other factors that influence caries risk include tooth anatomy, saliva composition and flow rate, diet, and oral hygiene. Poor oral hygiene allows more plaque to
Urolithiasis ( Kidney Stones) For ClinicalMedicine.pptxBarikielMassamu
This document discusses urolithiasis, or urinary stones. It defines urolithiasis and describes the most common types of stones based on their chemical composition. Calcium stones are the most prevalent. Risk factors for developing stones include age, sex, family history, diet, and medical conditions like gout. Clinical features can include flank pain, infection, hematuria, or being asymptomatic. Investigations like ultrasound, KUB, CT scan, and IVU may be used. Treatments depend on whether there is infection or pain. Complications can include scarring, infection, fistulae, or obstruction leading to hydronephrosis and chronic kidney disease.
The document discusses antidiarrheals and laxatives. It describes the mechanisms, indications, side effects and nursing implications of different classes of antidiarrheal and laxative agents. The main classes covered are adsorbents, anticholinergics, opiates, bulk forming laxatives, emollients, hyperosmotics, salines and stimulant laxatives. It provides details on how each class works, examples of common medications, appropriate uses, potential side effects and important considerations for patient education and monitoring.
how the dental calculus contributes in progression gingival disease and bone destruction, types of calculus,formation theories,calculus attachment to dental calculus,detection methods
This document discusses the evaluation of renal stones in children. It begins with a case scenario of a 15-year-old boy presenting with left flank pain and hematuria. It then provides introductions to kidney stones, urolithiasis, nephrolithiasis, and nephrocalcinosis. The document discusses the epidemiology, incidence, stone formation process, types of kidney stones including calcium, uric acid, struvite and cystine stones. It outlines risk factors, pathophysiology, approach to diagnosis including detailed history, clinical examination, investigations such as imaging tests, urine analysis and blood tests. It provides details on imaging findings, normal urine constituent levels, the method of stone analysis and algorithms
This document summarizes urinary lithiasis (kidney stones). It discusses the epidemiology, physicochemistry, and classification of stones. Key points include that stone prevalence is highest in white males aged 40-60 and in hot, dry climates. Stones form when the concentration product of stone-forming salts in urine exceeds the solubility product, allowing crystallization. Randall's plaques act as nucleation sites for stone formation in the kidney. The document also outlines various metabolic abnormalities that can cause different stone compositions, like hypercalciuria, hyperoxaluria, and hypocitraturia.
The document discusses renal calculi (kidney stones). It outlines factors in the environment that can contribute to kidney stone formation, including physical activity, work environment, nutrition, body mass, gender, ethnicity, and geographic location. It describes the normal functions of the kidneys and how alterations in physiological mechanisms can lead to renal calculus. Common types of stones are discussed along with their contributing factors and treatment options. Pharmacological treatments include thiazide diuretics, allopurinol, and sodium bicarbonate. Nursing considerations for patients taking these medications focus on monitoring for side effects and complications.
Cholelithiasis, or gallstones, can be either cholesterol stones or pigment stones. Cholesterol stones form when bile becomes supersaturated with cholesterol, while pigment stones are caused by elevated bilirubin levels. Risk factors for cholesterol stones include obesity, rapid weight loss, female sex hormones, and certain genetic disorders. Risk factors for pigment stones include chronic hemolytic anemias and infections of the biliary tract. Gallstones may be asymptomatic but can also cause pain, inflammation of the gallbladder or bile ducts, and other complications if they obstruct ducts or erode into other organs.
2nd year_SGD_Physiology of Liver & Gallbladder.pptmunshi5
The document provides an overview of the functions of the liver and gallbladder. It begins with learning objectives focused on describing the key functions and physiological mechanisms. It then covers the anatomical structures and blood supply of the liver and biliary system. The major sections provide details on the liver's secretory, metabolic, detoxification and other functions. Specific contents of bile like bile salts and pigments are discussed. Clinical correlations regarding jaundice, hepatitis, cirrhosis and gallstones are also summarized. Relevant liver function tests are outlined.
This document provides a case history and overview of cholelithiasis (gallstones). It begins with the case history of a 55-year-old male admitted with abdominal pain and vomiting who was diagnosed with acute gangrenous cholecystitis based on imaging. It then discusses the anatomy and physiology of the gallbladder, definitions and classifications of gallstones, risk factors, pathogenesis, clinical manifestations, diagnostic evaluations, and management. Management options discussed include nutritional therapy, pharmacological therapy, non-surgical methods like lithotripsy, and surgical methods like laparoscopic cholecystectomy.
This document provides an overview of alternatives to cholecystectomy for treating cholelithiasis (gallstones). It discusses the history and epidemiology of gallstone disease and outlines various nonsurgical treatment options including dissolution therapy using medications like ursodeoxycholic acid, extracorporeal shockwave lithotripsy to break up stones, and percutaneous techniques to remove stones. While cholecystectomy has long been the standard treatment, this document explores less invasive alternatives that may be suitable for certain patients depending on factors like stone composition and gallbladder function.
The document discusses theories of dental calculus formation. It describes calculus as mineralized dental plaque composed primarily of calcium phosphate. Several theories are presented on how calculus forms, including the booster mechanism, epitactic theory, inhibition theory, transformation theory, and enzymatic theory. The document also discusses the composition, prevalence, and etiological significance of calculus in periodontal disease progression.
This document provides an overview of renal stones (kidney stones). It discusses the classification of stones by location and chemical composition, which includes calcium salts, uric acid, magnesium ammonium phosphate, and cystine stones. The causes, risk factors, and pathogenesis of different stone types are explained. For example, calcium oxalate stones may be caused by hypercalcemia, hypercalciuria, or hyperoxaluria. The document also covers the morphology, clinical features, diagnosis, and treatment of renal stones.
This document provides an overview of renal stones (kidney stones). It discusses the classification of stones by location and chemical composition, which includes calcium salts, uric acid, magnesium ammonium phosphate, and cystine stones. The causes, risk factors, and pathogenesis of different stone types are explained. Calcium oxalate and uric acid stones are the most common. The document also covers the morphology, clinical features, diagnosis, and treatment of renal stones.
The document describes the anatomy and physiology of the urinary tract and kidney, risk factors and types of kidney stones, and methods for diagnosing and treating stones, including increasing fluid intake, altering diet, using medications to change urine composition, and surgically removing stones with procedures like ureteroscopy and lithotripsy. Kidney stones form when substances like calcium, oxalate, and uric acid become supersaturated in the urine and crystallize into solid masses.
Stone disease evaluation in Pathology laboratory: Current prospective.Sanjeev Mehta
This document discusses metabolic evaluation and stone analysis for kidney stones. It explains that stone analysis identifies the stone composition and underlying causes, which helps determine the appropriate treatment plan. A variety of tests are used, including blood and urine tests, 24-hour urine collection to measure supersaturation levels, and analyzing the stone composition. Integrating the results of these analyses can identify metabolic abnormalities and other factors in 90-95% of cases, guiding personalized medical management and prevention of future stone recurrences.
This document discusses urinary stone disease (kidney stones). It reviews the epidemiology, risk factors, pathogenesis and types of kidney stones. It also reviews guidelines for management from the American Urological Association. The main points are:
- Kidney stone prevalence is increasing worldwide, especially for calcium stones. Risk factors include metabolic syndrome, obesity, diabetes and cardiovascular disease.
- The major stone types are calcium oxalate, calcium phosphate, uric acid and struvite. Composition depends on urine composition and risk factors.
- Pathogenesis involves supersaturation of urine leading to crystallization of stone-forming substances. Hypocitraturia and hyperoxaluria are common contributing factors.
-
The document discusses diarrhea and constipation, and treatments for each. It describes antidiarrheal agents that work by adsorption, decreasing motility, modifying intestinal flora, or decreasing motility. Side effects include electrolyte imbalances, constipation, and drug interactions. Laxatives are used to treat constipation and work by bulking stool, lubricating, drawing water into intestines, or increasing motility. Side effects include electrolyte issues, cramps, and dependency with long term use. Nursing implications include assessing for dehydration and educating patients.
Kidney stones form when minerals crystallize and separate from urine inside the kidney. They are typically small in size but can cause pain by blocking the flow of urine. Common symptoms include pain during urination, back pain, and blood in the urine. While diet and dehydration are key risk factors, kidney stones sometimes form without a clear cause. Diagnosis involves x-rays or ultrasounds to detect stones in the kidneys or ureters. Shock wave lithotripsy is a common treatment that uses sonic waves to break up stones so they can pass naturally in urine.
1. Dental plaque plays a key role in the development of dental caries by acting as a barrier that prevents saliva from neutralizing acids and remineralizing enamel. Within plaque, cariogenic bacteria like Streptococcus mutans ferment sugars into acids that dissolve enamel.
2. Frequent sugar consumption promotes the growth of cariogenic bacteria in plaque and shortens the time between acid attacks on teeth before remineralization can occur, increasing the risk of caries. Sucrose is particularly cariogenic.
3. Other factors that influence caries risk include tooth anatomy, saliva composition and flow rate, diet, and oral hygiene. Poor oral hygiene allows more plaque to
Urolithiasis ( Kidney Stones) For ClinicalMedicine.pptxBarikielMassamu
This document discusses urolithiasis, or urinary stones. It defines urolithiasis and describes the most common types of stones based on their chemical composition. Calcium stones are the most prevalent. Risk factors for developing stones include age, sex, family history, diet, and medical conditions like gout. Clinical features can include flank pain, infection, hematuria, or being asymptomatic. Investigations like ultrasound, KUB, CT scan, and IVU may be used. Treatments depend on whether there is infection or pain. Complications can include scarring, infection, fistulae, or obstruction leading to hydronephrosis and chronic kidney disease.
The document discusses antidiarrheals and laxatives. It describes the mechanisms, indications, side effects and nursing implications of different classes of antidiarrheal and laxative agents. The main classes covered are adsorbents, anticholinergics, opiates, bulk forming laxatives, emollients, hyperosmotics, salines and stimulant laxatives. It provides details on how each class works, examples of common medications, appropriate uses, potential side effects and important considerations for patient education and monitoring.
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
Physiology and chemistry of skin and pigmentation, hairs, scalp, lips and nail, Cleansing cream, Lotions, Face powders, Face packs, Lipsticks, Bath products, soaps and baby product,
Preparation and standardization of the following : Tonic, Bleaches, Dentifrices and Mouth washes & Tooth Pastes, Cosmetics for Nails.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
How to Fix the Import Error in the Odoo 17Celine George
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
2. Objectives
• to be able to enumerate the different causes of urinary stones
• to be able to discuss the pathogenesis of stone formation
• to be able to explain the different Physicochemical phases of stone
formation
• to be enumerate the different inhibitors of crystal formation
• To be able to discuss the classification of renal stones
4. epidemiology of renal calculi
• Global annual prevalence rate: 3% - 5%
• Life time prevalence: 15%-25%
• rate of recurrence after 1st time:
• 1st year: 14%
• 5th year: 35%
• 10th year: 52%
5. epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• typically affects adult males than adult
women
• however, according to a study
“..resource utilization for urinary stone
disease rose 22% for men and 52% for
women, reflecting an increasing
resource use in women compared to
men.” --
6. epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• prevalence by Race is highest among
white males> Hispanics> Asians>
African-Americans
7. epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• uncommon < 20 years old
• peak incidence: 4th to 6th decade of life
• in women, bimodal distribution of
stone disease occurs
• a 2nd peak occurs on the 6th decade
corresponding to the onset of
menopause
8. epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• roughly follows environmental risk
factors
• higher prevalence in:
• hot
• arid
• dry climates
9. epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• seasonal variation in stone disease is
likely related to temperature by way of
fluid losses from perspiration &
sunlight induced increases in vitamin D
11. epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• prevalence & incident risk are directly
correlated with weight and BMI in both
sexes
• higher BMI associated w/ increase
excretion of:
• Urinary oxalate
• Uric Acid
• Sodium
• Phosphorus
12. epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• urinary supersaturation of uric acid
increases with increasing BMI
• association of obesity w/ calcium oxalate
stone formation is primarily due to
increased excretion of promoters of stone
formation
• association of obesity and uric acid stone
is primarily influenced by urinary pH
13. epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• water intake is inversely related to
kidney stone formation
• geographical differences on incidence
of stone disease have been associated
to the difference in the mineral &
electrolyte content of water
14. physicochemistry
• stone formation is a cascade of events that occurs as the glomerular
filtrate traverses the nephron
• starts w/ urine becoming supersaturated w/ respect to stone forming
salts
• crystals that are formed may flow with the urine
• however, some crystals become retained in the kidney thru anchoring
sites that promote growth and aggregation of crystal leading to stone
formation
15. physicochemistry
state of saturation
• concentration product: a solution containing ions/ molecules of a
sparingly soluble salt
• Saturated solution: a state when a pure aqueous solution of a salt
reaches the point at which no further added salt crystals will dissolve
• addition of crystals to a saturated solution will cause crystals to
precipitate
• precipitation is influenced by:
• urine pH
• temperature
16. physicochemistry
state of saturation
• in urine however, crystallization does not necessarily occur because
of the presence of inhibitors and other molecules that may allow
higher concentration of salts without precipitation
• urine is considered to be metastable with respect to the salt
• Formation product: the point where the metastable state of urine can
no longer be held in solution so that crystal would already form
17. physicochemistry
state of saturation
• Three major states of saturation
in urine:
• undersaturated
• metastable
• unstable
• crystals would not form
• dissolution of crystals
theoretically can be done
18. physicochemistry
state of saturation
• Three major states of saturation
in urine:
• undersaturated
• metastable
• unstable
• state were most common
stone components reside
• precipitation does not occur
• modulation of factors
controlling stone formation
may be done
• therapeutic intervention is
performed at this state
19. physicochemistry
state of saturation
• Three major states of saturation
in urine:
• undersaturated
• metastable
• unstable
• nucleation will occur
• inhibitors not generally effective
20. physicochemistry
metastable urine state
• crystal growth can occur on existing crystal, but de novo formation of
crystals cannot occur in the length of time it normally takes for the
filtered urine to reach the bladder
• BUT crystal formation may occur on certain conditions
21. physicochemistry
metastable urine state: circumstances when crystals may grow
1. parts of the nephron where local concentration products may
exceed the formation product for long enough time periods to allow
nucleation to occur
2. local areas of obstruction/ stasis in the upper urinary tract may
prolong urinary transit time and allow crystals to form
3. microscopic impurities/ other constituents in the urine can facilitate
the nucleation process by absorption of the crystal components in a
geometric way that ensemble the native crystals
22. physicochemistry
Nucleation & Crystal growth, aggregation and retention
• Homogenous nucleation is the process by which nuclei form in pure
solution
• Nuclei are the earliest crystal structure that does not dissolve
• Small nuclei is unstable favoring dissolution of the crystal over crystal
growth
• Nuclei would persist if:
• supersaturation level is reached
• size of the crystal is adequate
• urine transit time is longer that the lag time to nucleation
23. physicochemistry
Nucleation & Crystal growth, aggregation and retention
• crystal growth occurs when:
• promoters stabilize the nuclei
thus providing a surface with
a binding site that
accommodates the crystal
structure of the nucleus
• crystal nuclei usually form
through heterogeneous
nucleation by adsorption
onto existing surfaces of
epithelial cells, cell debris or
other crystals
• Inhibitors of crystal growth
• Magnesium
• Citrate
• Nephrocalcin
• Tamm-Horsfall mucoprotein
• Uropontin
• Bikunin
24. physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism, tubular
plugs
• Fixed-particle mechanism, papillary
plaques
• starts with formation of crystals
inside the nephron
• if the crystals are removed it
becomes harmless crystalluria
• if not, retention of crystals leads
either to:
• particles too large to pass
• particles adhere to damaged
cells
25. physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism, tubular
plugs
• Fixed-particle mechanism, papillary
plaques
• retained crystals can:
• enter the interstitium
• form plugs inside tubules/ ducts
of Bellini
• crystal plugs were seen in patients
w/:
• primary hyperoxaluria
• primary hyperparathyroidism
• enteric hyperoxaluria
• distal renal tubular acidosis
26. physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism, tubular
plugs
• Fixed-particle mechanism, papillary
plaques
• these conditions have increase
serum and renal load of Calcium,
Oxalate & Cystine:
• primary hyperoxaluria
• primary hyperparathyroidism
• enteric hyperoxaluria
• high renal load leads to increased
intratubular concentrations further
increasing crystallization
27. physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism,
tubular plugs
• Fixed-particle mechanism,
papillary plaques
• overall, plugs consist of random
aggregates formed due to an
acute high supersaturation of
stone components
28. physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism, tubular
plugs
• Fixed-particle mechanism, papillary
plaques
• initial step in papillary plaque
formation is precipitation of
calcium phosphate in the
interstitium around the bends of
the longest loops of Henle
• with alternating accumulation of
crystal components and organic
material these deposits increase in
size
• the growing plaque gets exposed to
the urine space outside the papilla
29. physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism, tubular
plugs
• Fixed-particle mechanism, papillary
plaques
• Plaque formation in the
interstitium may form during
periods of increased reabsorption
of calcium & phosphate
• this leads to a supersaturation in
the interstitial space
• since water in the interstitium is
static this allows the salts to
crystalize
30. physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism,
tubular plugs
• Fixed-particle mechanism,
papillary plaques
• overall, this mechanism contains
an initial period of deposition
outside the dynamics of urine
flow
• this is followed by growth and
eventual exposure to urine
31. physicochemistry
inhibitors & promoters of crystal formation
• presence of molecules that raises the supersaturation needed to
initiate crystal nucleation/ reduce rate of crystal growth to prevent
stone formation have been identified
• Known Inhibitors of crystal formation:
• Citrate
• Magnesium
• Pyrophosphate
32. physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of crystal
formation:
• Citrate
• Magnesium
• Pyrophosphate
• acts as an inhibitor of calcium
oxalate and calcium phosphate
stone formation by:
• complexes with calcium to
decrease available ionic
calcium for binding with
oxalate or phosphate
• inhibits spontaneous
precipitation of calcium
oxalate
33. physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of crystal
formation:
• Citrate
• Magnesium
• Pyrophosphate
• acts as an inhibitor of calcium
oxalate and calcium phosphate
stone formation by: cont..
• prevents agglomeration of
calcium oxalate
• reduced calcium phosphate
growth
• prevents heterogeneous
nucleation of calcium oxalate
by monosodium urate
34. physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of
crystal formation:
• Citrate
• Magnesium
• Pyrophosphate
• it’s action is derived from its complex
with oxalate
• this complex reduces available ionic
oxalate concentrations and decrease
calcium oxalate supersaturation
• it also reduces the rate of calcium
oxalate crystal growth
35. physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of
crystal formation:
• Citrate
• Magnesium
• Pyrophosphate
• inorganic pyrophosphate is
responsible for 25% - 50% of the
inhibitory activity of whole urine
against calcium phosphate
crystallization
36. physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of calcium
oxalate monohydrate crystal
aggregation:
• Nephrocalcin
glycoprotein
• Tamm-Horsfall
glycoprotein
• Osteopontin/ Uropontin
• is an acidic glycoprotein that is
synthesized in the proximal
convoluted tubules and the thick
ascending limb
• inhibits growth of calcium oxalate
monohydrate crystals
37. physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of calcium
oxalate monohydrate crystal
aggregation:
• Nephrocalcin
glycoprotein
• Tamm-Horsfall
glycoprotein
• Osteopontin/ Uropontin
• expressed by renal epithelial cells in the
thick ascending limb and distal
convoluted tubule as a membrane-
anchored protein that is released into
the urine after the anchoring site is
cleaved by phospholipase or proteases
• most abundant protein in the urine
• potent inhibitor of calcium oxalate
crystal aggregation
38. physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of
calcium oxalate
monohydrate crystal
aggregation:
• Nephrocalcin
• Tamm-Horsfall
glycoprotein
• Osteopontin/
Uropontin
• expressed in bone matrix and renal
epithelial cells of the ascending limb
of the loop of Henle and distal tubule
• inhibits nucleation, growth and
aggregation of calcium oxalate crystal
• also reduces binding of crystals to
renal epithelial cells
39. mineral metabolism
• Calcium absorption primarily occurs in the small intestines at a rate
that is dependent on calcium intake
• 1,25-Dihydroxyvitamin D, is the most potent stimulator of intestinal
calcium absorption
• PTH stimulate 1α-hydroxylase in the proximal tubule of the kidney to
convert 25-dihydroxyvitamin D3 to 1,25(OH)2D3
• PTH enhances proximal tubular reabsorption of calcium and renal
phosphate excretion
• Intestinal oxalate absorption is influenced by luminal calcium,
magnesium and oxalate-degrading bacteria
41. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• nearly 75% of all urinary calculi contain
calcium
• Hypercalciuria
• most common abnormality identified
• but not all persons w/ hypercalciuria
develop stones
42. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hypercalciuria
• stone formation may occur with:
• increase urinary saturation of calcium
salts
• decrease inhibitory activity of citrate
& chondroitin sulfate
43. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hypercalciuria
• definitions:
• > 200 mg urinary calcium/day, after
adherence to a 400 mg calcium, 100
mg sodium diet x 1 week (Menon, 1986)
• excretion of greater than 4
mg/kg/day or greater than 7
mmol/day in men and 6 mmol/day
in women (Parks and Coe, 1986)
44. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hyperoxaluria
• definitions: urinary oxalate >40 mg/day
• leads to urinary saturation of calcium
oxalate that leads to calcium oxalate
stones formation
• it is also involve in crystal growth and
retention by means of renal tubular
cell injury by lipid peroxidation and
generation of oxygen free radicals
45. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous Stones
• Hyperoxaluria may be due to:
• primary hyperoxaluria
• derangement in biosynthesis
• enteric hyperoxaluria
(malabsorption conditions)
• inflammatory bowel disease
• celiac sprue
• intestinal resection
• Dietary hyperoxaluria
• excessive dietary intake of
vitamin C
46. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hyperuricosuria
• urinary uric acid > 600mg/day
• 10% of calcium stone formers have
hyperuricosuria as the only
abnormality
• most common cause is increase dietary
intake of purine
47. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hypocitraturia
• urinary citrate level of:
• < 320 mg/day (Park, 1987)
• < 0.6 mmol (men), 1.03 mmol
(women)/day (Menon and Mahle, 1983)
• cause by:
• metabolic acidosis due to enhanced
renal tubular reabsorption
• decrease synthesis of citrate in
peritubular cells
48. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Low Urine pH
• defined as: < 5.5
• may be due to:
• high amount of dissociated uric acid
• chronic metabolic acidosis
• gouty diathesis- formation of
urinary stones in persons w/ 1o gout
49. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous Stones
• Renal Tubular Acidosis
• characterized by metabolic
acidosis resulting from
defects in renal tubular
hydrogen ion secretion/
bicarbonate reabsorption
• Types of RTA:
• Type 1
• Type II
• Type III
50. Renal Tubular Acidosis
• Normal: kidney must reabsorb filtered bicarbonate to maintain
buffering action
• Excess acid must likewise be excreted
• failure of the two mechanism lead to metabolic acidosis:
• decrease buffer (bicarbonate)
• increase acid (decrease acid secretion in the tubules)
• RTA occurs due to an impairment of
• net acid excretion (Type1)
• reabsorption of bicarbonate (Type 2)
51. types of renal tubular acidosis
• Type 1 (Distal)
• Type 2 (Proximal)
• Type 4 (Distal)
• characterized by an abnormal collecting duct
function w/c is the inability to acidify the
urine in the presence of systemic acidosis
• classic findings:
• hypokalemia
• hypercholerimia
• non-anion gap metabolic acidosis
• nephrocalcinosis
• elevated urine (>6.0)
52. types of renal tubular acidosis
• Type 1 (Distal)
• Type 2 (Proximal)
• Type 4 (Distal)
• most common associated stone is Calcium
Phosphate because of:
• hypercalciuria
• hypocitraturia: most important factor in
stone formation for type 1
• increased urinary pH
• Metabolic acidosis promote:
• bone demineralization
• which lead to hyperparathyroidism
• Hypercalceuria
53. types of renal tubular acidosis
• Type 1 (Distal)
• Type 2
(Proximal)
• Type 4 (Distal)
• characterized by a defect in bicarbonate
reabsorption associated with:
• initial high urine pH that normalizes as
plasma HCO3
- decreases
• decrease in amount of filtered HCO3
-
• nephrolithiasis is uncommon due to a
normal citrate excretion
• affects the proximal tubule function
• Stone is not common due to a normal
citrate excretion
54. types of renal tubular acidosis
• Type 1 (Distal)
• Type 2
(Proximal)
• Type 4 (Distal)
• associated w/ chronic renal damage
seen in patients w/
• interstitial renal disease
• diabetic nephropathy
• stone formation is not common due to
a reduced excretion of stone-forming
substances such as calcium and uric
acid
55. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hypomagnesuria
• rare cause of nephrolithiasis
• magnesium binds with oxalate and
calcium thus reducing Mg inhibitory
activity
• Low urinary Mg level associated with
decreased urinary citrate levels, w/c.
further contributes to stone formation
56. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous Stones
• determinants of uric acid stone formation
• low pH
• most important pathogenic factor
• low urine volume
• hyperuricosuria
• stone formation may be due to:
• congenital causes
• acquired causes
• idiopathic causes
57. uric acid stone formation
causes
• Congenital disorders
• Acquired
• Idiopathic
• associated with:
• Defects in renal tubular urate
reabsorption
• Lesch-Nyhan syndrome
• 1o a defect in purine metabolism
• deficiency of hypoxanthine-guanine
phosphoribosyltransferase (HGPRT)
• leads to build up of uric acid in all
body fluids
58. uric acid stone formation
causes
• Congenital disorders
• Acquired
• Idiopathic
• associated with:
• Familial Juvenile Gouty Nephropathy
• characterized by elevated serum
uric acid concentrations
• due to abnormal reabsorption of
uric acid
59. uric acid stone formation
causes
• Congenital disorders
• Acquired
• Idiopathic
• chronic diarrhea
• volume depletion
• myeloproliferative disorders
• high animal protein intake
• intake of uricosuric drugs (ex.
colchicine, allopurinol)
60. uric acid stone formation
causes
• Congenital disorders
• Acquired
• Idiopathic
• gouty diathesis/ idiopathic low urine pH
• manifest with:
• normal uric acid levels (does not
have gout)
• acidic urine
• Hyperuricosuric calcium nephrolithiasis
• manifest with:
• hyperuricosuria
• normal urine pH
61. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• main component is cystine
• due to crystallization of cystine in urine
• Factors determining crystallization of
cystine in urine:
• urinary cystine concentration
• urine pH
• ionic strength
• urinary macromolecules
62. Factors determining crystallization of cystine
in urine
• urinary cystine
concentration
• urine pH
• ionic strength
• urinary macromolecules
• supersaturation of cystine in the
urine is the main contributor
• due to:
• no specific inhibitor for cystine
crystallization
• poor solubility of cystine in
urine
63. Factors determining crystallization of cystine
in urine
• urinary cystine
concentration
• urine pH
• ionic strength
• urinary macromolecules
• cystine solubility is pH
dependent
• Solubility of cystine at particular
pH:
• 300 mg/L : pH 5
• 400 mg/L: pH 7
• 1000 mg/L: pH 9
• Average urine pH: 6
64. Factors determining crystallization of cystine
in urine
• urinary cystine
concentration
• urine pH
• ionic strength
• urinary macromolecules
• Ionic strength influences the
solubility of cystine
• so that an increase in ionic
strength of urine from 0.005 to
0.3 will allow an addition of 70
mg of cystine to be dissolved
65. Factors determining crystallization of cystine
in urine
• urinary cystine
concentration
• urine pH
• ionic strength
• urinary macromolecules
• colloids can also increase
cystine solubility
• but the mechanism is still
unclear
66. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• primarily composed of Magnesium
Ammonium Phosphate Hexahydrate called
struvite
• prerequisite in its formation is infection
with a urease-producing bacteria
• urinary urea is hydrolyzed to ammonia +
CO2 (produces alkaline urine, pH 7.2 - 8.0)
67. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• but alkaline pH favors the formation of
ammonia
• however in the presence of urease,
ammonia continues to be produced
despite the alkaline pH
• this further increases the pH of urine
68. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Alkaline pH also promotes hydration of CO2 to
Carbonic acid
• Carbonic acid dissociates into bicarbonate + 2
Hydrogen ions
69. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Dihydrogen phosphate in the alkaline urine
promotes dissociation to produce phosphate
ions
• Add Magnesium into the mixture you would
have:
• Ammonium + Phosphate + Magnesium =
Magnesium Ammonium Phosphate
• Infection stones may also be exacerbated with:
• urinary obstruction
• urine stasis
70. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Common pathogens associated:
• Proteus
• P. mirabilis: most common organism
causing struvite stones
• Klebsiella
• Pseudomonas
• Staphylococcus
• incidence is higher in women than in men
(2:1)
71. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• radiolucent stone formed due to:
• congenital deficiency of
xanthine oxidase
• results into plasma
accumulation and excess
urinary excretion of xanthine
• xanthine is poorly soluble in
urine leading to
supersaturation with the
subsequent development of
xanthine stones
72. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• radiolucent stone formed due to:
• congenital deficiency of adenine
phosphoribosyltransferase
(APRT)
• leads to formation and
hyperexcretion of
dihydroxyadenine (DHA)
• low solubility of DHA leads
to precipitation and
formation of urinary crystals
that may grow and form
urinary stones
73. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• rare cause of urinary stones,
seen in <1% of all stone formers
• conditions associated include:
• laxative abuse
• recurrent UTI
• recurrent uric acid stone
formation
• inflammatory bowel disease
74. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• Pathophysiology has been postulated
to be due to:
• dehydration 2o GI losses (from
abuse of laxatives) causing:
• intracellullar acidosis
• enhanced ammonia excretion
• Urinary sodium is low because of
dehydration
• urate complexes with ammonia
leading to urinary supersaturation
of ammonium acid urate
75. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• also known as fibromas/ colloid
calculi/ albumin calculi
• such stones are made of
mucopolysaccharide (1/3) + protein
(2/3)
76. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• most common amino acids found
were:
• threonine
• leucine
• serine
• tyrosine
• arginine
• lysine
77. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• formation may be due to:
• direct precipitation and
crystallization of a drug or its
metabolite
• indirectly by altering the urinary
environment favorable for
metabolic stone formation
78. pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• Drugs associated with calcium stone
formation
• loop diuretics (furosemide)
• acetazolamide: a carbonic
anhydrase inhibitor
• topiramate: use for seizure
disorders and migraine
• zonisamide: sulfonamide
anticonvulsant and carbonic
anhydrase inhibitor
79. anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
80. anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• incidence of renal stones in this
abnormality is about 20%
• however studies show that
metabolic abnormalities play a big
role in the development of urinary
stones among these patients
81. anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• evidence on the role of metabolic
predisposition:
• high rate of recurrence of stone
formation after correction
• metabolic evaluation
demonstrated an underlying
metabolic abnormality
• type and distribution of
metabolic abnormality
identified in UJO patients where
similar to the general population
82. anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• therefore: correction of UPJ
obstruction does not prevent stone
formation from recurring
83. anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• occurs in 0.25% of the
population and renal stone
incidence among them is 20%
• because of the high insertion of
the ureter into the renal pelvis
there is impairment of urine
drainage
84. anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• Although, risk of stone
formation has been related to
urinary stasis
• underlying metabolic
abnormalities are still needed
for the formation of stones
85. anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• associated in 40% of patients w/
stones
• unclear if the stone formation is
caused by local obstruction or
because of metabolic factors
86. anatomic predisposition to stone formation
• Ureteropelvic Junction Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• characterized by ectasia of the renal
collecting ducts
• associated with:
• recurrent infection
• urinary stasis
• hypercalciuria
• impaired renal concentrating
ability
• defective urinary acidification
87. anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• possible contributing factor for
stone formation:
• defective renal acidification
• Hypercalciuria
• Hypocitraturia
88. stones in pregnancy
• physiologic changes during pregnancy may enhance stone formation
• physiologic hydronephrosis brought about by:
• high levels of progesterone
• compression of the ureters by the gravid uterus
• Hydronephrosis may persist up to 4 to 6 weeks postpartum
• physiologic dilatation may:
• promote crystallization due to urinary stasis
• increase renal pelvic pressure
89. stones in pregnancy
• Other physiologic changes that may modulate risk factors for the
development of urinary stone
• increase renal blood flow
• increase GFR
• increase filtered loads of:
• calcium
• sodium
• uric acid